Ignite Creation Date:
2024-05-06 @ 4:16 PM
Last Modification Date:
2024-10-26 @ 2:07 PM
Study NCT ID:
NCT04939662
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2021-06-02
Brief Title:
Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects
Sponsor:
Se-Hoon Lee
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
SUKSES-B2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Se-Hoon Lee
Lead Sponsor Class:
OTHER
Responsible Party:
Se-Hoon Lee
Responsible Party Title:
Samsung Medical Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Samsung Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |
| AstraZeneca | INDUSTRY |